A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma

Clinical trial NCT07023315 · RECRUITING

Trial details

NCT number: NCT07023315
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

Start date: 2025-08-14
Primary completion: 2029-07-01
Enrollment: 760

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.